Clinical Trials Search at Vanderbilt-Ingram Cancer Center
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
Multiple Cancer Types
The objective of this study is to evaluate the efficacy and safety of sacituzumab
govitecan-hziy monotherapy and with novel combinations in participants with metastatic
urothelial cancer (mUC).
govitecan-hziy monotherapy and with novel combinations in participants with metastatic
urothelial cancer (mUC).
Bladder,
Urologic
II
Davis, Nancy
NCT03547973
VICCURO18120
